{"schema_version":"secwatch.filing_event.v1","accession":"0000105770-25-000031","form_type":"8-K","ticker":"WST","cik":"0000105770","company_name":"WEST PHARMACEUTICAL SERVICES INC","filed_at":"2025-04-24T23:59:59+00:00","discovered_at":"2026-05-14T18:02:47.354205+00:00","generated_at":"2026-05-23T06:38:24.794135+00:00","sec_items":["5.02","9.01"],"event_type":"leadership","sentiment":"neutral","materiality_score":0.6,"calibrated_materiality_score":0.6,"confidence":"high","headline":"West Pharma CFO Birkett to retire; Campbell named Chief Proprietary Segment Officer","bullets":["CFO Bernard Birkett informed West of intention to retire; search for successor initiated; will remain until transition and then advisory role through Dec 31, 2025.","Shane Campbell appointed SVP, Chief Proprietary Segment Officer effective May 5, 2025; previously at Carlisle Companies and DuPont.","Campbell receives $600K base salary, 75% target bonus (2025 prorated), $1M LTI award (50% PSUs, 25% options, 25% RSUs), $400K sign-on RSU (4-year vest), and $100K sign-on cash bonus.","Birkett joined West in June 2018 and served as CFO, also as CFO & COO from 2022 to April 2024."],"urls":{"canonical":"https://secwatch.observer/filing/0000105770-25-000031","json":"https://secwatch.observer/filing/0000105770-25-000031.json","markdown":"https://secwatch.observer/filing/0000105770-25-000031.md","text":"https://secwatch.observer/filing/0000105770-25-000031.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/105770/000010577025000031/0000105770-25-000031-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/105770/000010577025000031/wst-20250422.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-23T06:38:24.794135+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"6b8c7e4d7b","claim":"Shane Campbell was appointed as Senior Vice President, Chief Proprietary Segment Officer at WEST PHARMACEUTICAL SERVICES INC.","evidence_excerpt":"On April 24, 2025, the Company announced that it had appointed Shane Campbell to serve as Senior Vice President, Chief Proprietary Segment Officer, effective May 5, 2025","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/105770/000010577025000031/0000105770-25-000031-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"appointed"},{"label":"Role","value":"Senior Vice President, Chief Proprietary Segment Officer"}],"fact_type":"executive_change"},{"claim_id":"fbbdfd6972","claim":"Bernard Birkett departed as Senior Vice President & Chief Financial Officer at WEST PHARMACEUTICAL SERVICES INC.","evidence_excerpt":"On April 22, 2025, Mr. Bernard Birkett notified West Pharmaceutical Services, Inc. (the “Company”) of his intention to retire as Senior Vice President & Chief Financial Officer later this year.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/105770/000010577025000031/0000105770-25-000031-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"intends to retire"},{"label":"Role","value":"Senior Vice President & Chief Financial Officer"}],"fact_type":"executive_change"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}